What's new

Recent content by sbmc27

  1. S

    Beximco’s Covid drug now available in stores, to cost Tk70 per capsule

    VEMBER 09, 2021 Beximco’s Covid drug now available in stores, to cost Tk70 per capsule COVID-19 IN BANGLADESH Tawsia Tajmim 09 November, 2021, 01:50 pm Last modified: 09 November, 2021, 05:10 pm Photo: Courtesy " style="box-sizing: inherit; cursor: pointer;"> Photo: Courtesy A locally...
  2. S

    Export sees record over 60% growth in Oct

    ER 03, 2021 Export sees record over 60% growth in Oct ECONOMY Jasim Uddin 02 November, 2021, 06:45 pm Last modified: 02 November, 2021, 11:15 pm The October earnings were 13.7% higher than the amount earned in September Bangladesh has recorded its highest ever single-month export...
  3. S

    Motorcycle industry enters 500CC era

    The Business Standard WEDNESDAY, OCTOBER 20, 2021 Motorcycle industry enters 500CC era TRANSPORT Mahfuz Ullah Babu 19 October, 2021, 10:45 pm Last modified: Ifad Motors is allowed to manufacture up to 500cc bikes Highlights: Requirements for 500cc motorbikes Import Policy Order 2021-24 has...
  4. S

    Bangladesh likely to settle for bottling Chinese vaccines in coproduction bid

    Janssen COVID vaccine or Johnson &Johnson vaccine. Produced by Janssen vaccine in Leiden, Netherlands and it's Belgian parent company.
  5. S

    Astrazeneca Vaccine: Bangladesh wants to produce it locally

    Incepta pharma selected for the production of Sputnik V vaccine. https://media-eng.dhakatribune.com/extra/wateraids-mobile.jpeg Ads Home Bangladesh Bangladesh approves Russia’s Sputnik V Covid-19 vaccine for emergency use Tribune Report Published at 01:59 pm April 27th, 2021 Sputnik V...
  6. S

    Bangladesh yet to respond on India's offer to manufacture Covaxin

    Incepta pharma has been selected for SputnikV vaccine production.
  7. S

    Bill passed in parliament to promote engineering research

    Looks like BMRC (Bangladesh medical research Council). BMRC merely acts as a statutory body /legal framework Through which research can be done.
  8. S

    Chinese chemical maker rebuffs pandemic fears, wants to invest $300m

    Same proposal. They’re planning to invest 300 mil initially.
  9. S

    Lifting private investment would be a tall order

    Tuesday, July 28, 2020 YOUR RIGHT TO KNOW Home Business 12:00 AM, July 27, 2020 / LAST MODIFIED: 02:25 AM, July 27, 2020 Lifting private investment would be a tall order 4 Shares Rejaul Karim Byron The government is aiming to lift private investment to GDP ratio to a record 25.3 per cent...
  10. S

    Chinese chemical maker rebuffs pandemic fears, wants to invest $300m

    Tuesday, July 28, 2020 YOUR RIGHT TO KNOW Home Business 12:00 AM, July 27, 2020 / LAST MODIFIED: 12:59 AM, July 27, 2020 Chinese chemical maker rebuffs pandemic fears, wants to invest $300m 21 Shares Jagaran Chakma Yabang Investment Holdings Group Co Ltd, a concern of Yabang Group of...
  11. S

    Maharashtra clears import of Remdesivir, an antiviral drug w Read more at: https://mumbaimirror.ind

    Maharashtra clears import of Remdesivir, an antiviral drug Read more at: https://mumbaimirror.indiatimes.com/mumbai/cover-story/state-clears-import-of-remdesivir/articleshow/76239550.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
  12. S

    Eskayef first to produce Remdesivir in the country First generic Remdesivir in the world

    Na bhai, actually Smith, Kline and French company was acquired by Transcom BD, owned by businessman Latifur Rahman, back in 1990. The same businesses house owned two of the most prominent newspapers, The Daily Star and Prothom Alo. The pharma company renamed as Eskayef in 2017.
  13. S

    Eskayef first to produce Remdesivir in the country First generic Remdesivir in the world

    Good competition. Sunday, May 10, 2020 YOUR RIGHT TO KNOW Home Front Page 12:00 AM, May 10, 2020 / LAST MODIFIED: 02:30 AM, May 10, 2020 Remdesivir: Eskayef submits samples to DGDA Staff Correspondent Leading pharmaceuticals company Eskayef yesterday submitted samples of remdesivir...
Back
Top Bottom